ATE44751T1 - Zusammensetzungen zum behandeln von ischaemie im gehirn. - Google Patents

Zusammensetzungen zum behandeln von ischaemie im gehirn.

Info

Publication number
ATE44751T1
ATE44751T1 AT84308976T AT84308976T ATE44751T1 AT E44751 T1 ATE44751 T1 AT E44751T1 AT 84308976 T AT84308976 T AT 84308976T AT 84308976 T AT84308976 T AT 84308976T AT E44751 T1 ATE44751 T1 AT E44751T1
Authority
AT
Austria
Prior art keywords
treatment
ichaemia
brain
compositions
dynorphin
Prior art date
Application number
AT84308976T
Other languages
English (en)
Inventor
Yoshio Hosobuchi
Nancy M Lee
Horace H Loh
Jaw-Kang Chang
Original Assignee
Yoshio Hosobuchi
Nancy M Lee
Horace H Loh
Chang Jaw Kang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshio Hosobuchi, Nancy M Lee, Horace H Loh, Chang Jaw Kang filed Critical Yoshio Hosobuchi
Application granted granted Critical
Publication of ATE44751T1 publication Critical patent/ATE44751T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT84308976T 1983-12-22 1984-12-20 Zusammensetzungen zum behandeln von ischaemie im gehirn. ATE44751T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56474183A 1983-12-22 1983-12-22
EP84308976A EP0147194B1 (de) 1983-12-22 1984-12-20 Zusammensetzungen zum Behandeln von Ischämie im Gehirn

Publications (1)

Publication Number Publication Date
ATE44751T1 true ATE44751T1 (de) 1989-08-15

Family

ID=24255692

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84308976T ATE44751T1 (de) 1983-12-22 1984-12-20 Zusammensetzungen zum behandeln von ischaemie im gehirn.

Country Status (5)

Country Link
EP (1) EP0147194B1 (de)
JP (1) JPS60156619A (de)
AT (1) ATE44751T1 (de)
CA (1) CA1252718A (de)
DE (1) DE3447720C2 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396606A (en) * 1979-11-05 1983-08-02 Addiction Research Foundation Novel polypeptide analgesics
US4462941A (en) * 1982-06-10 1984-07-31 The Regents Of The University Of California Dynorphin amide analogs
US4481191A (en) * 1983-03-30 1984-11-06 The Regents Of The University Of California Method for controlling blood pressure

Also Published As

Publication number Publication date
EP0147194B1 (de) 1989-07-19
CA1252718A (en) 1989-04-18
JPH0577654B2 (de) 1993-10-27
DE3447720A1 (de) 1985-07-11
JPS60156619A (ja) 1985-08-16
DE3447720C2 (de) 1993-11-04
EP0147194A2 (de) 1985-07-03
EP0147194A3 (en) 1987-04-29

Similar Documents

Publication Publication Date Title
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
ATE76294T1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
DE68917219D1 (de) Therapeutisches Erzeugnis zur Behandlung von Beschwerden während der oder nach den Wechseljahren.
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
ES8701783A1 (es) Procedimiento para la fabricacion de derivados peptidos analogos de la pepstatina.
DE69226877D1 (de) Behandlung der hiv-assoziierten immun-thrombopenie purpura
EP0166612A3 (en) Potent thymopentin analogs
ATE145136T1 (de) Verwendung von ketoconazol und ein retinoid zur behandlung der akne vulgaris
GR3027620T3 (en) Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products
CS8708732A2 (en) Method of hv1, hv2, hv3 hirodin forms' one variant production
AU579593B2 (en) Novel peptides which are active on the central nervous system and have an action on the cholinergic system
NZ218170A (en) Piperidine derivatives and pharmaceutical compositions
FI871304A0 (fi) Menetelmä nootrooppisen vaikutuksen omaavien aminohappojohdannaisten valmistamiseksi
EP0319962A3 (de) Piperidinyl-Methanol-Derivate zur Behandlung von Angstzuständen
ATE239470T1 (de) Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen
EP0305181A3 (en) Ethyl-(+)-apovincaminate for treating demyelinization clinical patterns of autoimmune origin
ATE44751T1 (de) Zusammensetzungen zum behandeln von ischaemie im gehirn.
HU896448D0 (en) Process for the preparation of anticoagulant peptides
CA1268468C (en) PROSTAGLANDIN ANALOGS WITH SUBSTITUTE THIABICYCLOHEPTAN GROUP
EP0235904A3 (de) Behandlung von Allergie mit Thymopentin
ATE81972T1 (de) Zusammensetzungen und verfahren zur behandlung von magengeschwueren.
ZA815094B (en) Novel peptide
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds
DE3586752D1 (de) Verfahren zur herstellung wundheilungsfoerdernder praeparationen und solche praeparationen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee